| Today's News and Trends | ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161. ART-101 is a prostate-specific membrane antigen-targeting small molecule that can pair with multiple isotopes, including actinium-225, lutetium-177 and terbium-161. | | |
| Spontaneous ICH carries a heightened risk of mortality, making locating its origin in a timely manner critical to outcomes. Spontaneous ICH carries a heightened risk of mortality, making locating its origin in a timely manner critical to outcomes. | | |
| The organization is worried the paper's estimates will cause patients to “forgo necessary, lifesaving medical imaging." The organization is worried the paper's estimates will cause patients to “forgo necessary, lifesaving medical imaging." | | |
| The new device marks a “significant step forward” in American stroke care, the company contends. The new device marks a “significant step forward” in American stroke care, the company contends. | | |
| CT for severe PPH cases could help identify the source of bleeding with greater accuracy, leading to improved management and outcomes. CT for severe PPH cases could help identify the source of bleeding with greater accuracy, leading to improved management and outcomes. | | |
| | Leveraging the upsides of RPM with AI demands human attention to numerous challenges. Primary among these are privacy and cybersecurity risks, researchers report. Leveraging the upsides of RPM with AI demands human attention to numerous challenges. Primary among these are privacy and cybersecurity risks, researchers report. | | |
| Over 38% of mammography facilities are within 1 mile of a nearby LCS provider, and 60% of this segment share the same address. Over 38% of mammography facilities are within 1 mile of a nearby LCS provider, and 60% of this segment share the same address. | | |
| Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology. Rishi Wadhera, MD, MPP, MPhil, a cardiologist who also specializes in healthcare policy, spoke to Cardiovascular Business about the good, the bad and the unknown when it comes to private equity's role in cardiology. | | |
| |
|
| ![]() | |
|